🇯🇵 Japan Country × Condition
gastric cancer Clinical Trials in Japan
Active clinical trials for gastric cancer with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇯🇵 Japan
Active Trials in Japan (3)
NCT06490159
Recruiting
Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
Enrollment
150 pts
Country
🇯🇵 Japan
City of Hope Medical Center
View Trial → NCT06038578 Phase 2
Recruiting
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Enrollment
146 pts
Country
🇯🇵 Japan
Toray Industries, Inc
View Trial → NCT05702229 Phase 2
Recruiting
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment
163 pts
Country
🇯🇵 Japan
AstraZeneca
View Trial → Frequently Asked Questions
How many gastric cancer clinical trials are active in Japan?
There are currently 3 active clinical trials for gastric cancer with sites in Japan, of which 3 are actively recruiting patients.
How can I join a gastric cancer clinical trial in Japan?
To join a gastric cancer clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastric cancer trials in Japan?
Active gastric cancer trials in Japan span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology